Successful treatment of the underlying malignancy—whether by surgical resection, chemotherapy, or radiation—frequently leads to stabilization of the neurological disease, a reduction in relapse rates, and, in some documented cases, a decrease in or complete seroreversion of AQP4-IgG titers (13). The gene discussed is AQP4; the disease is nervous system disorder.